Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6899890 | PADAGIS US | Bioadhesive drug delivery system |
Apr, 2023
(a month from now) | |
US9789057 | PADAGIS US | Pharmaceutical delivery system |
Dec, 2026
(3 years from now) |
Drugs and Companies using CLINDAMYCIN PHOSPHATE ingredient
Market Authorisation Date: 30 November, 2004
Treatment: Method of treating bacterial vaginosis
Dosage: CREAM;VAGINAL
11
United States
5
China
4
Australia
3
Brazil
3
Argentina
3
Korea, Republic of
3
Canada
3
Japan
3
European Union
1
Portugal
1
Singapore
1
Malaysia
1
Russia
1
Mexico
1
Peru
1
France
1
EA
1
South Africa
1
Hungary
1
Italy
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6978945 | PADAGIS US | Dispensing device |
Jul, 2022
(7 months ago) |
Drugs and Companies using ESTRADIOL ingredient
Market Authorisation Date: 27 July, 2007
Treatment: NA
Dosage: SPRAY;TRANSDERMAL
5
Australia
2
Korea, Republic of
2
New Zealand
2
Japan
1
Hungary
1
United States
1
Canada
1
Russia
1
Mexico
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic